Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

Azenta will support the collaboration by delivering genomic sequencing through GENEWIZ and managing long-term sample storage within its global biorepository network. With decades of experience in ...

On July 14, 2025 Fresenius filed two IPR petitions challenging Regeneron’s patents related to aflibercept. Regeneron has not asserted that ...

A downtrend has been apparent in Fresenius (FMS) lately. While the stock has lost 9.1% over the past four weeks, it could ...

Investors in Fresenius Medical Care AG FMS need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $12.50 Call had some of the highest ...

Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have ...

Fresenius Medical Care (FMS) is rated a buy, with shares up 32.95% YoY and strong Q1 2025 results, showing 60% (YoY) net ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy Award ...

LAKE ZURICH, Ill., July 17, 2025--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy ...

Willmar has been home to a dialysis clinic since the 1960s when the city-owned Rice Memorial Hospital established a program. The clinic is now operated by Fresenius Kidney Care in a new location.

Fresenius Kabi continues the expansion of its biosimilars portfolio in the U.S. with the introduction of Conexxence (denosumab-bnht) and Bomyntra® (denosumab-bnht) in the United States ...